Join us for Part 1 of this two-part series on Clinical Trials from the Patient Perspective. We review some of the basics about clinical trials for people living with MBC and share personal stories from our co-hosts Lisa Laudico and Sheila McGlown. The team was joined by podcast members, Jim Kremens and Sarah Mann, as we spoke with patient advocates Lianne Kraemer and Christine Hodgdon. The team then had a series of conversations with Lisa’s oncology team, Dr. Neal Fischbach of Yale New Haven Health, Dr. Corrie Painter of Count Me In and the Broad Institute, bioethicist Jill Manning of Mass General Brigham and Kirstin Schneeman of Fasters Cures and the Milken Institute. We spend time discussing the current challenges with clinical trials with each of these experts and set the stage for Part 2 of this series when we will discuss solutions to make clinical trials better for people living with MBC.
Part 2 of Clinical Trials from the Patient Perspective will be in your podcast feed on March 29, 2021.
More info available on our website www.ourmbclife.org
Got something to share? Feedback?
Email: [email protected]
Send us a voice recording via email or through speakpipe on our website.
Follow us on Facebook, Instagram, and Twitter @ourmbclife